DNA immunization with plasmids encoding fusion and nucleocapsid proteins of bovine respiratory syncytial virus induces a strong cell-mediated immunity and protects calves against challenge.
[en] Respiratory syncytial viruses (RSV) are one of the most important respiratory pathogens of humans and cattle, and there is currently no safe and effective vaccine prophylaxis. In this study, we designed two codon-optimized plasmids encoding the bovine RSV fusion (F) and nucleocapsid (N) proteins and assessed their immunogenicity in young calves. Two administrations of both plasmids elicited low antibody levels but primed a strong cell-mediated immunity characterized by lymphoproliferative response and gamma interferon production in vitro and in vivo. Interestingly, this strong cellular response drastically reduced viral replication, clinical signs, and pulmonary lesions after a highly virulent challenge. Moreover, calves that were further vaccinated with a killed-virus vaccine developed high levels of neutralizing antibody and were fully protected following challenge. These results indicate that DNA vaccination could be a promising alternative to the classical vaccines against RSV in cattle and could therefore open perspectives for vaccinating young infants.
Disciplines :
Veterinary medicine & animal health Immunology & infectious disease Microbiology
DNA immunization with plasmids encoding fusion and nucleocapsid proteins of bovine respiratory syncytial virus induces a strong cell-mediated immunity and protects calves against challenge.
Publication date :
2007
Journal title :
Journal of Virology
ISSN :
0022-538X
eISSN :
1098-5514
Publisher :
American Society for Microbiology (ASM), Washington, United States - District of Columbia
André, S., B. Seed, J. Eberle, W. Schraut, A. Bültmann, and J. Haas. 1998. Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage. J. Virol. 72:1497-1503.
Antonis, A. F., E. A. Claassen, E. J. Hensen, R. J. de Groot, J. D. Groot-Mijnes, R. S. Schrijver, and R. G. van der Most. 2006. Kinetics of antiviral CD8 T cell responses during primary and post-vaccination secondary bovine respiratory syncytial virus infection. Vaccine 24:1551-1561.
Antonis, A. F. G., R. S. Schrijver, F. Daus, P. J. G. M. Steverink, N. Stockhofe, E. J. Hensen, J. P. M. Langedijk, and R. G. van der Most. 2003. Vaccine-induced immunopathology during bovine respiratory syncytial virus infection: exploring the parameters of pathogenesis. J. Virol. 77:12067-12073.
Arbiza, J., G. Taylor, J. A. Lopez, J. Furze, S. Wyld, P. Whyte, E. J. Stott, G. Wertz, W. Sullender, and M. Trudel. 1992. Characterization of two antigenic sites recognized by neutralizing monoclonal antibodies directed against the fusion glycoprotein of human respiratory syncytial virus. J. Gen. Virol. 73: 2225-2234.
Babiuk, L. A., S. L. Babiuk, and M. E. Baca-Estrada. 2002. Novel vaccine strategies. Adv. Virus Res. 58:29-80.
Bembridge, G. P., N. Rodriguez, R. Garcia-Beato, C. Nicolson, J. A. Melero, and G. Taylor. 2000. DNA encoding the attachment (G) or fusion (F) protein of respiratory syncytial virus induces protection in the absence of pulmonary inflammation. J. Gen. Virol. 81:2519-2523.
Boxus, M., C. Letellier, and P. Kerkhofs. 2005. Real time RT-PCR for the detection and quantitation of bovine respiratory syncytial virus. J. Virol. Methods 125:125-130.
Brady, R. P., C. L. Topliff, and C. L. Killing. 2004. In vitro expression of full-length and truncated bovine respiratory syncytial virus G proteins and their antibody responses in BALB/c mice. Vaccine 22:3762-3768.
Brunak, S., J. Engelbrecht, and S. Knudsen. 1991. Prediction of human mRNA donor and acceptor sites from the DNA sequence. J. Mol. Biol. 220:49-65.
Bukreyev, A., I. M. Belyakov, G. A. Prince, K. C. Yim, K. K. Harris, J. A. Berzofsky, and P. L. Collins. 2005. Expression of interleukin-4 by recombinant respiratory syncytial virus is associated with accelerated inflammation and a nonfunctional cytotoxic T-lymphocyte response following primary infection but not following challenge with wild-type virus. J. Virol. 79:9515-9526.
Cannon, M. J., P. J. Openshaw, and B. A. Askonas. 1988. Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus. J. Exp. Med. 168:1163-1168.
Chang, J., S. Y. Choi, H. T. Jin, Y. C. Sung, and T. J. Braciale. 2004. Improved effector activity and memory CD8 T cell development by IL-2 expression during experimental respiratory syncytial virus infection. J. Immunol. 172:503-508.
Connors, M., N. A. Giese, A. B. Kulkarni, C.-Y. Firestone, H. C. Morse III, and B. R. Murphy. 1994. Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10. J. Virol. 68:5321-5325.
Durbin, J. E., T. R. Johnson, R. K. Durbin, S. E. Mertz, R. A. Morotti, R. S. Peebles, and B. S. Graham. 2002. The role of IFN in respiratory syncytial virus pathogenesis. J. Immunol. 168:2944-2952.
Estes, D. M., and W. C. Brown. 2002. Type 1 and type 2 responses in regulation of Ig isotype expression in cattle. Vet. Immunol. Immunopathol. 90:1-10.
Gaddum, R. M., R. S. Cook, J. M. Furze, S. A. Ellis, and G. Taylor. 2003. Recognition of bovine respiratory syncytial virus proteins by bovine CD8+ T lymphocytes. Immunology 108:220-229.
Gaddum, R. M., R. S. Cook, L. H. Thomas, and G. Taylor. 1996. Primary cytotoxic T-cell responses to bovine respiratory syncytial virus in calves. Immunology 88:421-427.
Gershwin, L. J., R. A Gunther, M. L. Anderson, A. R. Woolums, K. McArthur-Vaughan, K. E. Randel, G. A. Boyle, K. E. Friebertshauser, and P. S. McInturff. 2000. Bovine respiratory syncytial virus-specific IgE is associated with interleukin-2 and -4, and interferon-gamma expression in pulmonary lymph of experimentally infected calves. Am. J. Vet. Res. 61:291-298.
Gershwin, L. J., E. S. Schelegle, R. A. Gunther, M. L. Anderson, A. R. Woolums, D. R. LaRochelle, G. A. Boyle, K. E. Friebertshauser, and R. S. Singer. 1998. A bovine model of vaccine enhanced respiratory syncytial virus pathophysiology. Vaccine 16:1225-1236.
Girard, M. P., T. Cherian, Y. Pervikov, and M. P. Kieny. 2005. A review of vaccine research and development: human acute respiratory infections. Vaccine 23:5708-5724.
Gurunathan, S., D. M. Klinman, and R. A. Seder. 2000. DNA vaccines: immunology, application, and optimization. Annu. Rev. Immunol. 18:927-974.
Gurunathan, S., C. Y. Wu, B. L. Freidag, and R. A. Seder. 2000. DNA vaccines: a key for inducing long-term cellular immunity. Curr. Opin. Immunol. 12:442-447.
Hagglund, S., K. F. Hu, L. E. Larsen, M. Hakhverdyan, J. F. Valarcher, G. Taylor, B. Morein, S. Belak, and S. Alenius. 2004. Bovine respiratory syncytial virus ISCOMs - protection in the presence of maternal antibodies. Vaccine 23:646-655.
Heegaard, P. M., D. L. Godson, M. J. Toussaint, K. Tjornehoj, L. E. Larsen, B. Viuff, and L, Ronsholt. 2000. The acute phase response of haptoglobin and serum amyloid A (SAA) in cattle undergoing experimental infection with bovine respiratory syncytial virus. Vet. Immunol. Immunopathol. 77: 151-159.
Hussell, T., C. J. Baldwin, A. O'Garra, and P. J. Openshaw. 1997. CD8+ T cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection. Eur. J. Immunol. 27:3341-3349.
Hussell, T., and P. J. Openshaw. 1998. Intracellular IFN-gamma expression in natural killer cells precedes lung CD8+ T cell recruitment during respiratory syncytial virus infection. J. Gen. Virol. 79:2593-2601.
Kalina, W. V., A. R. Woolums, R. D. Berghaus, and L. J. Gershwin. 2004. Formalin-inactivated bovine RSV vaccine enhances a Th2 mediated immune response in infected cattle. Vaccine 22:1465-1474.
Kerkhofs, P., M. Tignon, H. Petry, I. Mawhinney, and B. Sustronck. 2004. Immune responses to bovine respiratory syncytial virus (BRSV) following use of an inactivated BRSV-PI3-Mannheimia haemolytica vaccine and a modified live BRSV-BVDV vaccine. Vet. J. 167:208-210.
Kim, H. W., J. G. Canchola, C. D. Brandt, G. Pyles, R. M. Chanock, K. Jensen, and R. H. Parrott. 1969. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am. I. Epidemiol. 89:422-434.
Kozak, M. 1987. An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res. 15:8125-8148.
Larsen, L. E. 2000. Bovine respiratory syncytial virus (BRSV): a review. Acta Vet. Scand. 41:1-24.
Li, X., S. Sambhara, C. X. Li, L. Ettorre, I. Switzer, G. Cates, O. James, M. Partington, R. Oomen, R. P. Du, and M. Klein. 2000. Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate. Virology 269:54-65.
Li, X., S. Sambhara, C. X. Li, M. Ewasyshyn, M. Parrington, J. Caterini, O. James, G. Cates, R. P. Du, and M. Klein. 1998. Protection against respiratory syncytial virus infection by DNA immunization. J. Exp. Med. 188:681-688.
Mapletoft, J. W., M. Oumouna, H. G. Townsend, S. Gomis, L. A. Babiuk, and S. van Drunen Littel-van den Hurk. 2006. Formulation with CpG oligodeoxynucleotides increases cellular immunity and protection induced by vaccination of calves with formalin-inactivated bovine respiratory syncytial virus. Virology 353:316-323. [Epub 7 July 2006.]
Matheise, J. P., K. Walravens, A. Collard, P. Coppe, and J. J. Letesson. 1995. Antigenic analysis of the F protein of the bovine respiratory syncytial virus: identification of two distinct antigenic sites involved in fusion inhibition. Arch. Virol. 140:993-1005.
Mawhinney, I. C., and M. R. Burrows. 2005. Protection against bovine respiratory syncytial virus challenge following a single dose of vaccine in young calves with maternal antibody. Vet. Rec. 156:139-143.
Melkebeek, V., E. Sonck, F. Verdonck, B. M. Goddeeris, and E. Cox. 2007. Optimized FaeG expression and a thermolabile enterotoxin DNA adjuvant enhance priming of an intestinal immune response by an FaeG DNA vaccine in pigs. Clin. Vaccine Immunol. 14:28-35.
Mossadegh, N., L. Gissmann, M. Muller, H. Zentgraf, A. Alonso, and P. Tomakidi. 2004. Codon optimization of the human papillomavirus 11 (HPV 11) L1 gene leads to increased gene expression and formation of virus-like particles in mammalian epithelial cells. Virology 326:57-66.
Narum, D. L., S. Kumar, W. O. Rogers, S. R. Fuhrmann, H. Liang, M. Oakley, A. Taye, B. K. L. Sim, and S. L. Hoffman. 2001. Codon optimization of gene fragments encoding Plasmodium falciparum merozoite proteins enhances DNA vaccine protein expression and immunogenicity in mice. Infect. Immun. 69:7250-7253.
Openshaw, P. J. M., and J. S. Tregoning. 2005. Immune responses and disease enhancement during respiratory syncytial virus infection. Clin. Microbiol. Rev. 18:541-555.
Ostler, T., W. Davidson, and S. Ehl. 2002. Virus clearance and immunopathology by CD8(+) T cells during infection with respiratory syncytial virus are mediated by IFN-gamma. Eur. J. Immunol. 32:2117-2123.
Oumouna, M., J. W. Mapletoft, B. C. Karvonen, L. A. Babiuk, and S. van Drunen Littel-van den Hurk. 2005. Formulation with CpG oligodeoxynucleotides prevents induction of pulmonary immunopathology following priming with formalin-inactivated or commercial killed bovine respiratory syncytial virus vaccine. J. Virol. 79:2024-2032.
Ramakrishna, L., K. K. Anand, K. M. Mohankumar, and U. Ranga. 2004. Codon optimization of the Tat antigen of human immunodeficiency virus type 1 generates strong immune responses in mice following genetic immunization. J. Virol. 78:9174-9189.
Robinson, H. L., and T. M. Pertmer. 2000. DNA vaccines for viral infections: basic studies and applications. Adv. Virus Res. 55:1-74.
Rutigliano, J. A., T. R. Johnson, T. N. Hollinger, J. E. Fischer, S. Aung, and B. S. Graham. 2004. Treatment with anti-LFA-1 delays the CD8 + cytotoxic-T-lymphocyte response and viral clearance in mice with primary respiratory syncytial virus infection. J. Virol. 78:3014-3023.
Sandbulte, M. R., and J. A. Roth, 2003. Priming of multiple T cell subsets by modified-live and inactivated bovine respiratory syncytial virus vaccines. Vet. Immunol. Immunopathol. 95:123-133.
Schreiber, P., J. P. Matheise, F. Dessy, M. Heimann, J. J. Letesson, P. Coppe, and A. Collard. 2000. High mortality rate associated with bovine respiratory syncytial virus (BRSV) infection in Belgian white blue calves previously vaccinated with an inactivated BRSV vaccine. J. Vet. Med. B 47:535-550.
Schrijver, R. S., J. P. Langedijk, G. M. Keil, W. G. Middel, M. Maris-Veldhuis, J. T. Van Oirschot, and F. A. Rijsewijk. 1998. Comparison of DNA application methods to reduce BRSV shedding in cattle. Vaccine 16:130-134.
Shaw, G., and R. Kamen. 1986. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46:659-667.
Skinner, J. G., R. A. Brown, and L. Roberts. 1991. Bovine haptoglobin response in clinically defined field conditions. Vet. Rec. 128:147-149.
Srikiatkhachorn, A., and T. J. Braciale. 1997. Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection. J. Exp. Med. 186:421-432.
Stott, E. J., and G. Taylor. 1985. Respiratory syncytial virus. Brief review. Arch. Virol. 84:1-52.
Taylor, G., C. Bruce, A. F. Barbet, S. G. Wyld, and L. H. Thomas. 2005. DNA vaccination against respiratory syncytial virus in young calves. Vaccine 23: 1242-1250.
Taylor, G., L. H. Thomas, J. M. Furze, R. S. Cook, S. G. Wyld, R. Lerch, R. Hardy, and G. W. Wertz. 1997. Recombinant vaccinia viruses expressing the F, G or N, but not the M2, protein of bovine respiratory syncytial virus (BRSV) induce resistance to BRSV challenge in the calf and protect against the development of pneumonic lesions. J. Gen. Virol. 78:3195-3206.
Taylor, G., L. H. Thomas, S. G. Wyld, J. Furze, P. Sopp, and C. J. Howard. 1995. Role of T-lymphocyte subsets in recovery from respiratory syncytial virus infection in calves. J. Virol. 69:6658-6664.
Tjornehoj, K., A. Uttenthal, B. Viuff, L. E. Larsen, C. Rontved, and L. Ronsholt. 2003. An experimental infection model for reproduction of calf pneumonia with bovine respiratory syncytial virus (BRSV) based on one combined exposure of calves. Res. Vet. Sci. 74:55-65.
Toussaint, J. F., C. Letellier, D. Paquet, M. Dispas, and P. Kerkhofs. 2005. Prime-boost strategies combining DNA and inactivated vaccines confer high immunity and protection in cattle against bovine herpesvirus-1. Vaccine 23:5073-5081.
Tree, J. A., G. Bembridge, S. Hou, G. Taylor, E. Fashola-Stone, J. Melero, and M. P. Cranage. 2004. An assessment of different DNA delivery systems for protection against respiratory syncytial virus infection in the murine model: gene-gun delivery induces IgG in the lung. Vaccine 22:2438-2443.
Tristram, D. A., R. C. Welliver, D. A. Hogerman, S. W. Hildreth, and P. Paradiso. 1994. Second-year surveillance of recipients of a respiratory syncytial virus (RSV) F protein subunit vaccine, PFP-1: evaluation of antibody persistence and possible disease enhancement. Vaccine 12:551-556.
Tristram, D. A., R. C. Welliver, C. K. Mohar, D. A. Hogerman, S. W. Hildreth, and P. Paradiso. 1993. Immunogenicity and safety of respiratory syncytial virus subunit vaccine in seropositive children 18-36 months old. J. Infect. Dis. 167:191-195.
Valarcher, J. F., and G. Taylor. 2007. Bovine respiratory syncytial virus infection. Vet. Res. 38:153-180.
Van der Poel, W. H., A. Brand, J. A. Kramps, and J. T. Van Oirschot. 1994. Respiratory syncytial virus infections in human beings and in cattle. J. Infect. 29:215-228.
Varga, S. M., X. Wang, R. M. Welsh, and T. J. Braciale. 2001. Immunopathology in RSV infection is mediated by a discrete oligoclonal subset of antigen-specific CD4(+) T cells. Immunity 15:637-646.
Vaughan, K., G. H. Rhodes, and L. J. Gershwin. 2005. DNA immunization against respiratory syncytial virus (RSV) in infant rhesus monkeys. Vaccine 23:2928-2942.
Wahle, E., and W. Keller. 1996. The biochemistry of polyadenylation. Trends Biochem. Sci. 21:247-250.
Woodland, D. L. 2004. Jump-starting the immune system: prime-boosting comes of age. Trends Immunol. 25:98-104.
Woolums, A. R., R. A. Gunther, K. McArthur-Vaughan, M. L. Anderson, A. Omlor, G. A. Boyle, K. E. Friebertshauser, P. S. McInturff, and L. J. Gershwin. 2004. Cytotoxic T lymphocyte activity and cytokine expression in calves vaccinated with formalin-inactivated bovine respiratory syncytial virus prior to challenge. Comp. Immunol. Microbiol. Infect. Dis. 27:57-74.
Woolums, A. R., R. S. Singer, G. A. Boyle, and L. J. Gershwin. 1999. Interferon gamma production during bovine respiratory syncytial virus (BRSV) infection is diminished in calves vaccinated with formalin-inactivated BRSV. Vaccine 17:1293-1297.
